Abstract:BACKGROUND:Epithelial-to-mesenchymal transition (EMT) is involved in pathogenesis of human benign prostatic hyperplasia (BPH). Estrogenic signaling pathways may stimulate the induction of EMT. However, the details of estradiol (E2) and estrogen receptors (ERs) effects on EMT, as well as E2-induced modulation of benign prostatic epithelial cell phenotype in vitro have not been completely clarified. METHODS:The effects of E2 on EMT markers and cytokeratins (CKs) expression were evaluated in benign epithelial cell lines BPH-1 and RWPE-1, which were cultured both in two-dimensional (2D) culture and three-dimensional (3D) culture model using hanging drop technique or 3D Matrigel model. ER antagonist, ICI182,780, was used to confirm the regulatory effects of E2 on EMT and phenotypic modulation. In 3D culture, immunohistochemical stainings were performed to detect the specific phenotype of cells that underwent EMT in acinar-like spheroids formed by RWPE-1. To illustrate the exact function of ERs in E2-induced EMT and phenotypic modulation, specific short interfering RNAs (siRNAs), and agonists were used to knockdown or activate individual ERs, respectively. RESULTS:E2-induced EMT was observed both in 2D and 3D culture, with related regulation of EMT markers expression at both mRNA and protein level. In addition, E2 down-regulated luminal cell type markers CK18 and CK8 and up-regulated basal cell type markers CK5 and CK14. E2 also increased intermediate type markers CK15 and CK17, while it attenuated CK19 in 3D culture. ICI182,780 blocked E2-induced EMT and cell phenotypic switching. In 3D Matrigel culture, Vimentin was co-expressed with ERα and CK17, as well as with SMemb, which is related to cell status switching and proliferation. Knockdown of ERα but not GPR30 inhibited EMT, while ERβ knockdown facilitated EMT process. Knockdown of ERα blocked E2-induced EMT both in RWPE-1 and BPH-1. MRNA expression of EMT markers was stimulated by ERα-specific agonist PPT and inhibited by ERβ-specific agonist DPN. CONCLUSIONS:Estrogenic effect mediated by ERα can promote EMT. E2 is also an inductive factor of cell phenotypic switching. Cell type modulation is associated with E2-induced EMT in benign prostatic epithelial cells. Taken together the results support a contribution of estrogens to the pathogenesis of BPH in elderly men.

Relationship between the Expression of Estrogen Receptor α and Basal Cell Dedifferentiation in Benign Prostatic Hyperplasia

THE RELATIONSHIP OF THE PROLIFERATION AND PHENOTYPIC MODULATION OF THE STROMAL CELLS AND THE EXPRESSION OF ESTROGEN RECEPTOR α IN BENIGN PROSTATIC HYPERPLASIA

[Expression of Tyrosine Phosphatase Containing C-src Homology SH-2 in Benign Prostate Hyperplasia].

Expression of Nkx3.1 Enhances 17 Beta-Estradiol Anti-Tumor Action in PC3 Human Prostate Cancer Cells

Epithelial-to-mesenchymal Transition and Estrogen Receptor Α Mediated Epithelial Dedifferentiation Mark the Development of Benign Prostatic Hyperplasia

Estrogen regulates the proliferation and inflammatory expression of primary stromal cell in benign prostatic hyperplasia

Prostaglandin E2 Mediates Up-regulation of ERRα Expression with BPH-1 Condition Medium in Prostatic Stromal Cells

Expression and Significance of Estrogen Receptor Α and Β in Prostate Cancer and Peri-Cancer Tissue

Benign prostatic hyperplasia (BPH) epithelial cell line BPH-1 induces aromatase expression in prostatic stromal cells via prostaglandin E2.

[Expression of Estrogen Receptor Beta in Benign Prostatic Hyperplasia Complicated by Chronic Prostatitis].

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

Distribution and Prognostic Significance of Estrogen Receptors Expression in Prostate Cancer

Correlation Between Molecular Biomarkers and Risk Factors for the Clinical Progression of Benign Prostatic Hyperplasia Using Tissue Micro Array Immuno Staining

The Expression of Sexual Hormone Receptors and Related Growth Factors in Prostate Stromal Cell

Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.

Involvement of Estrogen Receptor Β in Androgen Receptor-Induced Growth Inhibition in Prostate Cancer PC-3 Cells.

Differential Expression of Genes in Co-Cultured Versus Separately Cultured Fibroblasts and Epithelial Cells from Human Benign Hyperplastic Prostate Tissues.

Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer

Expressions of the Androgen Receptor in Normal Prostate, Benign Prostatic Hyperplasia and Prostate Cancer

Expression of Angiogenic Inhibitors in Benign Prostate Hyperplasia and Prostate Cancer

[Expressions of Endothelin-1 in Benign Prostatic Hyperplasia and Prostate Cancer and Their Significance].